Literature DB >> 29795066

Non-operative management of rectal cancer: understanding tumor biology.

Iris H Wei1, Julio Garcia-Aguilar2.   

Abstract

The management of locally-advanced rectal cancer involves a combination of chemotherapy, chemoradiation, and surgical resection to provide excellent local tumor control and overall survival. However, aspects of this multimodality approach are associated with significant morbidity and long-term sequelae. In addition, there is growing evidence that patients with a clinical complete response to chemotherapy and chemoradiation treatments may be safely offered initial non-operative management in a rigorous surveillance program. Weighed against the morbidity and significant sequelae of rectal resection, recognizing how to best optimize non-operative strategies without compromising oncologic outcomes is critical to our understanding and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29795066      PMCID: PMC6252165          DOI: 10.23736/S0026-4733.18.07743-X

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  174 in total

Review 1.  Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.

Authors:  Patricio B Lynn; Paul Strombom; Julio Garcia-Aguilar
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 2.  A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.

Authors:  Fahima Dossa; Tyler R Chesney; Sergio A Acuna; Nancy N Baxter
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-05-04

3.  Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial.

Authors:  J F Bosset; V Magnin; P Maingon; G Mantion; E P Pelissier; M Mercier; G Chaillard; J C Horiot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

4.  Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma.

Authors:  Aziz Zaanan; Jae Myung Park; David Tougeron; Shengbing Huang; Tsung-Teh Wu; Nathan R Foster; Frank A Sinicrope
Journal:  Int J Cancer       Date:  2015-03-09       Impact factor: 7.396

5.  Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.

Authors:  Hak-Mien Quah; Joanne F Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Leonard B Saltz; Karyn A Goodman; Bruce D Minsky; W Douglas Wong; Martin R Weiser
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

6.  Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.

Authors:  Marjun P Duldulao; Wendy Lee; Leanne Streja; Peiguo Chu; Wenyan Li; Zhenbin Chen; Joseph Kim; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2013-02       Impact factor: 4.585

7.  Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.

Authors:  Yu Jo Chua; Yolanda Barbachano; David Cunningham; Jacqui R Oates; Gina Brown; Andrew Wotherspoon; Diana Tait; Alison Massey; Niall C Tebbutt; Ian Chau
Journal:  Lancet Oncol       Date:  2010-01-25       Impact factor: 41.316

8.  Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trial.

Authors:  Yan-Ru Feng; Yuan Zhu; Lu-Ying Liu; Wei-Hu Wang; Shu-Lian Wang; Yong-Wen Song; Xin Wang; Yuan Tang; Yue-Ping Liu; Hua Ren; Hui Fang; Shi-Ping Zhang; Xin-Fan Liu; Zi-Hao Yu; Ye-Xiong Li; Jing Jin
Journal:  Oncotarget       Date:  2016-05-03

9.  MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response.

Authors:  Vincent Ho; Liping Chung; Maxine Revoltar; Stephanie H Lim; Thein-Ga Tut; Askar Abubakar; Chris J Henderson; Wei Chua; Weng Ng; Mark Lee; Paul De Souza; Matthew Morgan; C Soon Lee; Joo-Shik Shin
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

10.  GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.

Authors:  Kunli Zhu; Qianqian Zhao; Jinbo Yue; Pengyue Shi; Hongjiang Yan; Xiaoqing Xu; Renben Wang
Journal:  Oncotarget       Date:  2016-10-18
View more
  1 in total

1.  Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.

Authors:  David D B Bates; Jennifer S Golia Pernicka; James L Fuqua; Viktoriya Paroder; Iva Petkovska; Junting Zheng; Marinela Capanu; Juliana Schilsky; Marc J Gollub
Journal:  Abdom Radiol (NY)       Date:  2020-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.